These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22789683)

  • 1. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
    Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
    Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia.
    Baran N; ter Braak M; Saffrich R; Woelfle J; Schmitz U
    Mol Cell Endocrinol; 2015 May; 407():18-25. PubMed ID: 25766501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
    Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
    Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias.
    Gorvin CM; Frost M; Malinauskas T; Cranston T; Boon H; Siebold C; Jones EY; Hannan FM; Thakker RV
    Hum Mol Genet; 2018 Nov; 27(21):3720-3733. PubMed ID: 30052933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating Mutations of the G-protein Subunit α 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2.
    Gorvin CM; Stokes VJ; Boon H; Cranston T; Glück AK; Bahl S; Homfray T; Aung T; Shine B; Lines KE; Hannan FM; Thakker RV
    J Clin Endocrinol Metab; 2020 Mar; 105(3):952-63. PubMed ID: 31820785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2).
    Piret SE; Gorvin CM; Pagnamenta AT; Howles SA; Cranston T; Rust N; Nesbit MA; Glaser B; Taylor JC; Buchs AE; Hannan FM; Thakker RV
    J Bone Miner Res; 2016 Jun; 31(6):1207-14. PubMed ID: 26818911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
    Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
    PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
    Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
    Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics.
    Mayr B; Glaudo M; Schöfl C
    Trends Endocrinol Metab; 2016 Sep; 27(9):643-652. PubMed ID: 27339034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant hypocalcemia due to a truncation in the C-tail of the calcium-sensing receptor.
    Maruca K; Brambilla I; Mingione A; Bassi L; Capelli S; Brasacchio C; Soldati L; Cisternino M; Mora S
    Mol Cell Endocrinol; 2017 Jan; 439():187-193. PubMed ID: 27561204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene.
    Chikatsu N; Watanabe S; Takeuchi Y; Muraosa Y; Sasaki S; Oka Y; Fukumoto S; Fujita T
    Endocr J; 2003 Feb; 50(1):91-6. PubMed ID: 12733714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterization of a novel calcium sensing receptor genetic alteration in a Greek patient with autosomal dominant hypocalcemia type 1.
    Papadopoulou A; Gole E; Melachroinou K; Trangas T; Bountouvi E; Papadimitriou A
    Hormones (Athens); 2017 Apr; 16(2):200-204. PubMed ID: 28742508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation.
    Tenhola S; Voutilainen R; Reyes M; Toiviainen-Salo S; Jüppner H; Mäkitie O
    Eur J Endocrinol; 2016 Sep; 175(3):211-8. PubMed ID: 27334330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report.
    Ji Y; Kang C; Chen J; Zhang L
    Medicine (Baltimore); 2021 Jun; 100(25):e26443. PubMed ID: 34160437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential parathyroid and kidney Ca
    van Megen WH; Tan RSG; Alexander RT; Dimke H
    EBioMedicine; 2022 Apr; 78():103947. PubMed ID: 35313217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review.
    Thim SB; Birkebaek NH; Nissen PH; Høst C
    Acta Paediatr; 2014 Nov; 103(11):1117-25. PubMed ID: 25039540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Matrix Mineralization in Patients With Gain-of-Function Calcium-Sensing Receptor Mutations Is Distinctly Different From that in Postsurgical Hypoparathyroidism.
    Ovejero D; Misof BM; Gafni RI; Dempster D; Zhou H; Klaushofer K; Collins MT; Roschger P
    J Bone Miner Res; 2019 Apr; 34(4):661-668. PubMed ID: 30496603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant hypocalcemia with a novel
    Wu Y; Zhang C; Huang X; Cao L; Liu S; Zhong P
    J Int Med Res; 2022 Jul; 50(7):3000605221110489. PubMed ID: 35818129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.